- Home
- KRC vs ACLX Comparison
KRC vs ACLX Comparison
Compare KRC & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRC
- ACLX
- Stock Information
- Founded
- KRC 1947
- ACLX 2015
- Country
- KRC United States
- ACLX United States
- Employees
- KRC N/A
- ACLX N/A
- Industry
- KRC Real Estate Investment Trusts
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- KRC Real Estate
- ACLX Health Care
- Exchange
- KRC Nasdaq
- ACLX Nasdaq
- Market Cap
- KRC N/A
- ACLX 3.3B
- IPO Year
- KRC 1997
- ACLX 2022
- Fundamental
- Price
- KRC $30.56
- ACLX $62.59
- Analyst Decision
- KRC Hold
- ACLX Strong Buy
- Analyst Count
- KRC 11
- ACLX 13
- Target Price
- KRC $38.82
- ACLX $110.82
- AVG Volume (30 Days)
- KRC 1.8M
- ACLX 641.0K
- Earning Date
- KRC 05-01-2025
- ACLX 05-08-2025
- Dividend Yield
- KRC 7.07%
- ACLX N/A
- EPS Growth
- KRC N/A
- ACLX N/A
- EPS
- KRC 1.77
- ACLX N/A
- Revenue
- KRC $1,135,629,000.00
- ACLX $107,936,000.00
- Revenue This Year
- KRC N/A
- ACLX N/A
- Revenue Next Year
- KRC $1.87
- ACLX $107.10
- P/E Ratio
- KRC $17.27
- ACLX N/A
- Revenue Growth
- KRC 0.53
- ACLX N/A
- 52 Week Low
- KRC $30.52
- ACLX $47.88
- 52 Week High
- KRC $43.78
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- KRC 30.72
- ACLX 41.70
- Support Level
- KRC $31.88
- ACLX $59.45
- Resistance Level
- KRC $33.38
- ACLX $67.34
- Average True Range (ATR)
- KRC 0.99
- ACLX 3.65
- MACD
- KRC -0.19
- ACLX -0.98
- Stochastic Oscillator
- KRC 1.20
- ACLX 23.26
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.